NCT00247481View on ClinicalTrials.gov

ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

77

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

June 30, 2005

Conditions

Breast Cancer

Interventions

DRUG

Gefitinib

DRUG

Docetaxel

Trial Locations (5)

Unknown

Research Site, Dijon

Research Site, Paris

Research Site, Saint-Cloud

Research Site, Saint-Germain-en-Laye

Research Site, Villejuif

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY